Nerve growth factor prevents the apoptosis-associated increase in acetylcholinesterase activity after hydrogen peroxide treatment by activating Akt

Acta Biochimica et Biophysica Sinica

Volumn 39, Issue 1, 2007, Pages 46-56

  Jiang, Hua ^a,c   Zhang, Jingya ^a,c   Zhu, Hui ^a,c   Li, Hong ^b   Zhang, Xuejun ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b UNIVERSITÉ DE ROUEN   (France)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Acetylcholinesterase (AChE); Akt; Apoptosis; Reactive oxygen species (ROS)

Indexed keywords

ACETYLCHOLINESTERASE; CASPASE 3; CYTOCHROME C; GLUTATHIONE; HYDROGEN PEROXIDE; NERVE GROWTH FACTOR; PROTEIN KINASE B;

ANIMAL; APOPTOSIS; ARTICLE; CELL STRAIN; DRUG EFFECT; ENZYME ACTIVATION; METABOLISM; PHOSPHORYLATION; RAT; SECRETION;

ACETYLCHOLINESTERASE; ANIMALS; APOPTOSIS; CASPASE 3; CYTOCHROMES C; ENZYME ACTIVATION; GLUTATHIONE; HYDROGEN PEROXIDE; NERVE GROWTH FACTOR; PC12 CELLS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS;

EID: 33846277250     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2007.00247.x     Document Type: Article

References (51)

1. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell 1997, 88: 347-354
2. Offen D, Elkon H, Melamed E. Apoptosis as a general cell death pathway in neurodegenerative diseases. J Neural Transm Suppl 2000, 58: 153-166
3. Talesa VN. Acetylcholinesterase in Alzheimer's disease. Mech Ageing Dev 2001, 122: 1961-1969
4. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981, 10: 122-126
5. Zhang XJ, Yang L, Zhao Q, Caen JP, He HY, Jin QH, Guo LH et al. Induction of acetylcholinesterase expression during apoptosis in various cell types. Cell Death Differ 2002, 9: 790-800
6. Melo JB, Agostinho P, Oliveira CR. Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid β-peptide. Neurosci Res 2003, 45: 117-127
7. Park SE, Kim ND, Yoo YH. Acetylcholinesterase plays a pivotal role in apoptosome formation. Cancer Res 2004, 64: 2652-2655
8. Wang R, Xiao XQ, Tang XC. Huperzine A attenuates hydrogen peroxide-induced apoptosis by regulating expression of apoptosis-related genes in rat PC12 cells. Neuroreport 2001, 12: 2629-2634
9. Wang R, Zhou J, Tang XC. Tacrine attenuates hydrogen peroxide-induced apoptosis by regulating expression of apoptosis-related genes in rat PC12 cells. Mol Brain Res 2002, 107: 1-8
10. Barbacid M. Structural and functional properties of the TRK family of neurotrophin receptors. Ann NY Acad Sci 1995, 766: 442-458
11. Shafer TJ, Atchison WD. Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: A model for neurotoxicological studies. Neurotoxicology 1991, 12: 473-492
12. Rieger F, Shelanski ML, Greene LA. The effects of nerve growth factor on acetylcholinesterase and its multiple forms in cultures of rat PC12 pheochromocytoma cells: Increased total specific activity and appearance of the 16 S molecular form. Dev Biol 1980, 76: 238-243
13. Ulrich E, Duwel A, Kauffmann-Zeh A, Gilbert C, Lyon D, Rudkin B, Evan G et al. Specific TrkA survival signals interfere with different apoptotic pathways. Oncogene 1998, 16: 825-832
14. Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: A hard Akt to follow. Trends Biochem Sci 2001, 26: 657-664
15. Downward J. How BAD phosphorylation is good for survival. Nat Cell Biol 1999, 1: E33-E35
16. Petrosillo G, Ruggiero FM, Paradies G. Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria. FASEB J 2003, 17: 2202-2208
17. Hengartner MO. The biochemistry of apoptosis. Nature 2000, 407: 770-776
18. Kennedy SG, Kandel ES, Cross TK, Hay N. Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol 1999, 19: 5800-5810
19. Gong J, Traganos F, Darzynkiewicz Z. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 1994, 218: 314-319
20. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961, 7: 88-95
21. Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 2000, 29: 323-333
22. Kaplowitz N, Aw TY, Ookhtens M. The regulation of hepatic glutathione. Annu Rev Pharmacol Toxicol 1985, 25: 715-744
23. Salinas M, Diaz R, Abraham NG, Ruiz de Galarreta CM, Cuadrado A. Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J Biol Chem 2003, 278: 13898-13904
24. 2 induce caspase-3-independent degradation of Akt/protein kinase B. J Biol Chem 2002, 277: 42943-42952
25. Zhou H, Li XM, Meinkoth J, Pittman RN. Akt regulates cell survival and apoptosis at a postmitochondrial level. J Cell Biol 2000, 151: 483-494
26. Pias EK, Aw TY. Early redox imbalance mediates hydroperoxide-induced apoptosis in mitotic competent undifferentiated PC-12 cells. Cell Death Differ 2002, 9: 1007-1016
27. Jin QH, He HY, Shi YF, Lu H, Zhang XJ. Overexpression of acetylcholinesterase inhibited cell proliferation and promoted apoptosis in NRK cells. Acta Pharmacol Sin 2004, 25: 1013-1021
28. Fridovich I. Fundamental aspects of reactive oxygen species, or what's the matter with oxygen? Ann N Y Acad Sci 1999, 893: 13-18
29. Kirkland RA, Franklin JL. Evidence for redox regulation of cytochrome C release during programmed neuronal death: Antioxidant effects of protein synthesis and caspase inhibition. J Neurosci 2001, 21: 1949-1963
30. 2: More evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun 2004, 315: 502-508
31. 2 modifies membrane structure and activity of acetylcholinesterase. Chem Biol Interact 2005, 157-158: 401-404
32. Eichler J, Silman I. The activity of an endoplasmic reticulum-localized pool of acetylcholinesterase is modulated by heat shock. J Biol Chem 1995, 270: 4466-4472
33. Grifman M, Arbel A, Ginzberg D, Glick D, Elgavish S, Shaanan B, Soreq H. In vitro phosphorylation of acetylcholinesterase at non-consensus protein kinase A sites enhances the rate of acetylcholine hydrolysis. Mol Brain Res 1997, 51: 179-187
34. Zhu H, Gao W, Jiang H, Jin QH, Shi YF, Tsim KW, Zhang XJ. Regulation of acetylcholinesterase expression by calcium signaling during calcium ionophore A23187- and thapsigargin-induced apoptosis. Int J Biochem Cell Biol 2007, 39: 93-108
35. Deng R, Li W, Guan Z, Zhou JM, Wang Y, Mei YP, Li MT et al. Acetylcholinesterase expression mediated by c-Jun-NH2-terminal kinase pathway during anticancer drug-induced apoptosis. Oncogene 2006, 25: 7070-7077
36. Velan B, Kronman C, Ordentlich A, Flashner Y, Leitner M, Cohen S, Shafferman A. N-glycosylation of human acetylcholinesterase: Effects on activity, stability and biosynthesis. Biochem J 1993, 296: 649-656
37. Saez-Valero J, Fodero LR, Sjogren M, Andreasen N, Amici S, Gallai V, Vanderstichele H et al. Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease. J Neurosci Res 2003, 72: 520-526
38. Yang L, He HY, Zhang XJ. Increased expression of intranuclear AChE involved in apoptosis of SK-N-SH cells. Neurosci Res 2002, 42: 261-268
39. Rokudai S, Fujita N, Hashimoto Y, Tsuruo T. Cleavage and inactivation of antiapoptotic Akt/PKB by caspases during apoptosis. J Cell Physiol 2000, 182: 290-296
40. Lawlor MA, Alessi DR. PKB/Akt: A key mediator of cell proliferation, survival and insulin responses? J Cell Sci 2001, 114: 2903-2910
41. Pilcher H. Alzheimer's disease could be "type 3 diabetes". Lancet Neurol 2006, 5: 388-389
42. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes? J Alzheimers Dis 2005, 7: 63-80
43. Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM. Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease. J Alzheimers Dis 2006, 9: 13-33
44. Verhoeff NP. Acetylcholinergic neurotransmission and the β-amyloid cascade: Implications for Alzheimer's disease. Expert Rev Neurother 2005, 5: 277-284
45. Reyes AE, Chacon MA, Dinamarca MC, Cerpa W, Morgan C, Inestrosa NC. Acetylcholinesterase-Aβ complexes are more toxic than Aβ fibrils in rat hippocampus: Effect on rat β-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss. Am J Pathol 2004, 164: 2163-2174
46. Geula C, Mesulam M. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease. Brain Res 1989, 498: 185-189
47. Sberna G, Saez-Valero J, Li QX, Czech C, Beyreuther K, Masters CL, McLean CA et al. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the β-amyloid protein precursor of Alzheimer's disease. J Neurochem 1998, 71: 723-731
48. Fadda F, Cocco S, Stancampiano R. Hippocampal acetylcholine release correlates with spatial learning performance in freely moving rats. Neuroreport 2000, 11: 2265-2269
49. Kuczewski N, Aztiria E, Domenici L. Developmental modulation of synaptic transmission by acetylcholine in the primary visual cortex. Brain Res 2006, 1095: 43-50
50. Catone C, Ternaux JP. Involvement of the α7 subunit of the nicotinic receptor in morphogenic and trophic effects of acetylcholine on embryonic rat spinal motoneurons in culture. J Neurosci Res 2003, 72: 46-53
51. Descarries L, Gisiger V, Steriade M. Diffuse transmission by acetylcholine in the CNS. Prog Neurobiol 1997, 53: 603-625